European Medicines Agency Urges Suspension of Pfizer’s Sickle Cell Drug Oxbryta Amid Safety Concerns
In a significant move, the European Medicines Agency (EMA) has recommended suspending the approval of Oxbryta, a medication developed by Pfizer for the treatment of...